| abstract |
In one embodiment, the present invention discloses a γ-secretase inhibitor of formula (I), wherein the various moieties are described herein. Also disclosed is a method of treating Alzheimer's disease using a compound of formula I or a composition containing a compound of formula (I). In one aspect, the invention provides novel compounds as inhibitors of γ-secretase, methods for preparing such compounds, compositions containing one or more such compounds, one or more Methods for preparing pharmaceutical formulations containing such compounds, methods for treating, preventing, preventing or ameliorating one or more diseases associated with γ-secretase using such compounds or pharmaceutical compositions provide. |